On August 3, 2018, Axcelis Technologies, Inc. (NASDAQ:AXLS), a microcap company based in Beverley, Mass, announced that it has entered into an agreement to acquire a $1.3 billion contract manufacturing facility in Korea.  The agreement is subject to court approval.  According to the SEC's complaint filed in the U.S. District Court for the Southern District of New York, Axcelis is not in a position to meet the $1.3 billion revenue target for the company.  The SEC's complaint alleges that Axcelis is not in a position to hit the $1.3 billion mark.  The SEC's complaint, filed in the U.S. District Court, alleges that Axcelis violated the antifraud provisions of Section 17(a) of the Securities Act of 1933 ("Securities Act") and Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 thereunder.  The settlement is subject to court approval.  The SEC's complaint charges Axcelis with violating Section 17(a) of the Securities Act and Section 10(b) of the Exchange Act and Rule 10b-5 thereunder, and seeks disgorgement of ill-gotten gains with prejudgment interest, penalties, and injunctive relief.  The SEC's investigation was conducted by Emily Duley and was supervised by Diana Widell, Virginia Dorsheimer and Virginia Dorsheimer.  The SEC appreciates the assistance of the U.S. Attorney's Office for the Southern District of New York and the Federal Bureau of Investigation.  The SEC's Office of Investor Education and Advocacy has issued anÂ Investor AlertÂ to encourage investors to check the background of anyone selling or offering them an investment using the free and simple search tool onÂ Investor.gov.  The SEC's Office of Investor Education has issued an Investor AlertÂ to encourage investors toÂ check the background of anyone selling or offering an investment usingÂ Investor.gov.